Cytosorbents Corp. (CTSO) — Analysis Summary
Cytosorbents Corp. (CTSO) has a market cap of $24.37M with year-over-year revenue growth of +4.1%. Net margin stands at -22.1%. The stock trades at a P/E ratio of -2.1.
Key Takeaways
- Revenue changed +4.1% year-over-year
- Net margin of -22.1%
- P/E ratio of -2.1
Compared to other companies in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector, CTSO posted revenue growth of +4.1% and trades at a P/E of -2.1.
Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.